Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications.
| Brand name | ARIPIPRAZOLE |
| Generic name | ARIPIPRAZOLE |
| Active ingredient(s) | ARIPIPRAZOLE |
| Distributed by / for | Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, By; Hetero Hetero Labs Limited Unit V Polepallly Jadcheria Mahaboob Nagar - 509 301 India |
| NDC | 31722-827-30 |
| Full product label | Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, By; Hetero Hetero Labs Limited Unit V Polepallly Jadcheria Mahaboob Nagar - 509 301 India, NDC 31722-827-30 |
| Recalling firm | Hetero Labs, Ltd. - Unit III |
| Distribution | NJ Only |
| Quantity | 3000 bottles |
| Recall initiated | 2018-01-10 |
| Report date | 2018-02-14 |
| Recall completed | 2020-09-21 |
| Recall number | D-0594-2018 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Hyderabad N/A India |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗